COMMUNIQUÉS West-GlobeNewswire

Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025
30/09/2025
TARRYTOWN, N.Y., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its third quarter 2025 financial and operating results on Tuesday, October 28, 2025 [...]
NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025
30/09/2025
PARIS et CAMBRIDGE, Mass., 30 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results
30/09/2025
PARIS and CAMBRIDGE, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand [...]
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
30/09/2025
Ad hoc announcement pursuant to Art. 53 LR Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment 1 Well-controlled disease observed as [...]
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/09/2025
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported [...]
The Beauty Health Company Names Pedro Malha President and Chief Executive Officer
30/09/2025
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., [...]
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
30/09/2025
TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
30/09/2025
Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) ( [...]
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF NOTE CONVERSION AGREEMENTS TO EXTINGUISH OVER TWO MILLION DOLLARS OF OUTSTANDING DEBT
30/09/2025
MINNEAPOLIS, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging [...]
AiM Medical Robotics Secures $8.1 Million Series A Financing to Transform Neurosurgery with MRI-Compatible Surgical Robotics
30/09/2025
— Financing round led by IQ Capital and 1540 Ventures accelerates path to first-in-human trials for groundbreaking robotic neurosurgical platform — WORCESTER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AiM Medical [...]
Evolution de la composition du Conseil d’administration
30/09/2025
Communiqué de presse Paris - Le 30 septembre 2025 - EUROAPI annonce aujourd’hui que conformément aux bonnes pratiques de gouvernance et à la suite de sa nomination en tant que directeur financier de Recipharm à compter [...]
Change in Board’s Composition
30/09/2025
Press Release Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1 st , 2025, [...]
BEYOND IMMORTALITY: European Wellness Biomedical Group Charts Longevity Through Cell Regeneration Over Organ Transplant
30/09/2025
From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing [...]
Major Wellbeing Organization Selects Aino’s SaaS Platform
30/09/2025
Aino Health AB (publ) has signed an agreement—facilitated through its occupational health collaboration partner Työterveys Aalto Occupational Health Care —with a leading wellbeing sector organization, covering 11,000 [...]
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium
30/09/2025
Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage” Ghent, Belgium – September 30, 2025 – Sequana Medical NV ( [...]
Clinical Match Me Announces Strategic Partnership with NPACE
30/09/2025
Clients to Benefit from Exclusive Discounts and Enhanced Educational Opportunities San Juan, PR, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Clinical Match Me , a transformative force in Nurse Practitioner education, NP [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2025
30/09/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 Septembre au 26 Septembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025
30/09/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 22nd to September 26th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
AB Science annonce annonce un léger décalage de la publication de son rapport financier du premier semestre 2025
30/09/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT FINANCIER SEMESTRIEL 2025 LA SOCIETE PUBLIERA SON RAPPORT FINANCIER SEMESTRIEL 2025 LE 10 OCTOBRE 2025 AU PLUS TARD Paris, 30 [...]

Pages